New Podcast; Most Read; BioBeats Resend & Trivia Answer

Research evidence excerpt

New Podcast; Most Read; BioBeats Resend & Trivia Answer

Biotechnology | Biotechnology |

Biotechnology

EQUITY RESEARCH Industry Report

July 19, 2026

New Podcast; Most Read; BioBeats Resend & Trivia

Companies mentioned

Ticker Price Rating Target Answer

ABCL 6.47 Overweight 11.00

ALGS $5.74 Overweight $20.00 We've introduced a new thematic monthly podcast entitled "The Control

ANL $11.53 Overweight - Arm" - for our first installment discussing the blurry lines of biotech, click

ATAI $7.22 Neutral - HERE.

AVBP $33.19 Overweight -

BIIB $205.99 Overweight $237.00 And click HERE for the link to our weekly BioBeats recording or open this

BMRN $59.59 Overweight $85.00 report for the slides. CMPS $12.35 Overweight $25.00

CNTB $2.38 Overweight $4.00

BioBeats Trivia Answer: $40B+ biopharma M&A transactions since 2010: HRMY $33.77 Overweight $50.00

IMCR $34.96 Overweight - ●PFE/SGEN: $43B, March 2023

INSM $108.32 Overweight $235.00 ●ABBV/AGN: $63B, June 2019

IVA $4.62 Overweight -

MANE $111.32 Overweight - ●BMY/CELG: $74B, Jan 2019

MDGL $553.48 Overweight - ●TAK/SHPG: $64B, May 2018

MESO $17.32 Overweight - ●TEVA/Actavis (from AGN): $40.5B, Aug 2016

MRK $127.50 Neutral $120.00

●AGN/Actavis: $68B, March 2015 MSLE $8.95 Overweight -

ORIC $10.73 Overweight -

Most-Read Cantor Research This Week: PTCT $78.59 Overweight $130.00

QTTB $15.05 Overweight -

RNA $12.15 Overweight $25.00 BioBUZZ- The Sky's the Limit? HERE

TYRA $32.13 Overweight - BioBUZZ Reduced Visibility - HERE

ZURA $5.45 Overweight -

Prices are as of 07/17/26. IMCR: TEBE-AM's Fast Approaching Interim Analysis - HERE

Research Analysts: Applying the Infamous Hazard Ratio - HERE

Josh Schimmer

310-282-6513 PM Corner With RTW's Rong Wong HERE

Josh.Schimmer@cantor.com

Eric Schmidt KOL Takeaways on Evolving GA Landscape HERE